Rhythm Pharmaceuticals, Inc. (RYTM) — SC 13G/A Filings
All SC 13G/A filings from Rhythm Pharmaceuticals, Inc.. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Feb 14, 2024
-
PRIMECAP Cuts Rhythm Pharma Stake to 13.9% as of Dec 31, 2023
— Feb 12, 2024 Risk: medium
PRIMECAP Management Company, an investment advisor, filed an amended SC 13G/A on February 12, 2024, disclosing its ownership in Rhythm Pharmaceuticals, Inc. As -
Goldman Sachs Amends Rhythm Pharma Stake; Ownership Update Filed
— Feb 5, 2024
Goldman Sachs Group Inc. filed an amended SC 13G/A on February 5, 2024, indicating a change in their beneficial ownership of Rhythm Pharmaceuticals, Inc. common -
BlackRock Amends RYTM Stake, Maintains Passive Position
— Jan 24, 2024
BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, indicating its ownership of RHYTHM PHARMACEUTICALS, INC. (NASDAQ: RYTM) Common Stock as of Decembe -
State Street Corp. Updates Stake in Rhythm Pharmaceuticals
— Jan 23, 2024
State Street Corporation, a major financial institution, filed an updated SC 13G/A on January 23, 2024, indicating its ownership in Rhythm Pharmaceuticals, Inc.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX